The most common synthesis routes consist of either solid-phase peptide synthesis (SPPS ... system of drug pricing controls is not quite what he first said it would be. In a new pharmaphorum ...

Alongside its expansion into low-scale oligo synthesis, the company has rebranded its custom oligos to better target ...

A prime example is First United Corporation (NASDAQ: FUNC). It maintains a solid topline performance, albeit its toppish growth recently. It also capitalizes on its well-positioned Balance Sheet ...

The first BMW EVs powered by all-solid-state batteries are now on the road for testing. BMW used an i7 to test the “holy grail” of EV battery tech, promising longer driving range at a lower cost.

which has entered the pre-production phase, the G-Yuan quasi-solid-state battery with a range of 1,000 kilometers, the G-Series batteries designed for 12-year use, and the world's first 20MWh ...

A research team led by Prof. Pavel Jungwirth at the Institute of Organic Chemistry and Biochemistry of the Czech Academy of ...

GEMSTONE All-Solid-State Battery: completing the first 0.2GWh pilot line Launched in 2024, Gotion's GEMSTONE all-solid-state battery now achieved a milestone by completing a 0.2GWh pilot ...

Granite (NYSE:GVA) has been awarded a Federally funded $54 million contract to build the first of two construction ... Public Facilities (DOT & PF). This phase of the project involves the ...

The developer behind the Golden Bear project in Upper Arlington already is eyeing an expansion before construction goes vertical on the first phase. Here's the latest on 3 notable projects in ...

The first phase of the government reduction plan to lower import duties under the National Tariff Policy 2025-30 will be implemented in the upcoming budget 2025-26 and will be fully implemented in ...

Just four months after finalizing production on the B61-12, the Pantex Plant has completed the first production unit (FPU) of the B61-13 nuclear gravity bomb, the National Nuclear Security ...

Oruka plans to initiate a Phase 2 study of ORKA-002 in moderate-to-severe psoriasis in the first half of 2026. The planned study design will evaluate the safety and efficacy of multiple dose ...